DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tivozanib is an investigational drug.
There have been 31 clinical trials for Tivozanib. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2010.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Renal Cell, and Colorectal Neoplasms. The leading clinical trial sponsors are AVEO Pharmaceuticals, Inc., National Comprehensive Cancer Network, and Roswell Park Cancer Institute.
Recent Clinical Trials for Tivozanib
|A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma||AstraZeneca||Phase 1/Phase 2|
|A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma||AVEO Pharmaceuticals, Inc.||Phase 1/Phase 2|
|Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC||Bristol-Myers Squibb||Phase 1/Phase 2|